Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06550856

SUTURE-CLOSURE OMENTOPEXY VERSUS OMENTOPEXY ALONE IN REPAIR OF PERFORATED PEPTIC ULCER

The present study will be conducted to assess whether there is a direct benefit associated with modified-Graham's omentopexy (MGO), above and beyond the benefit associated with Graham's omentopexy (GO) in the treatment of perforated duodenal ulcers. We attempted to answer the question whether primary closure of the perforation in MGO will affect the outcome of surgery. Complication rates will be compared for the two alternative surgical procedures.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sohag university Hospital

Sohag, Egypt

Location status: Recruiting

Location contact

Magdy M Amin, Professor

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All adult patients of both sexes with a clinical diagnosis of perforated peptic ulcer (gastric or duodenal) that are fit to undergo surgery.

Exclusion criteria

  • 1. Patients with associated bleeding ulcer (additional steps are needed to control bleeding).
  • Patients with associated pathology other than perforated peptic ulcer that needs surgical intervention.

Treatment and study plan

SUTURE-CLOSURE OMENTOPEXY IN REPAIR OF PERFORATED PEPTIC ULCER

Procedure

Patients presented with perforated peptic ulcer will be repaired using full thickness suture closure using 3/0 vicryl suture then omental patch laied over the sutures.

OMENTOPEXY ALONE IN REPAIR OF PERFORATED PEPTIC ULCER

Procedure

Patients presented with perforated peptic ulcer will be repaired by using omental patch without any attempt for primary closure of perforation.

Primary outcomes

  1. Early postoperative follow up for repair of perforated peptic ulcer

    Time frame: Three days after the operation

    resumption of oral intake

Study contacts

Contact information is provided by the study sponsor or research team.

Adel A Abdrabou, Resident

CONTACT

[email protected]

01014910091

Asem Elsani M Ali, Professor

CONTACT

0100 2613245

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 13, 2024
Registry last updated
Aug 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.